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Females have a more severe clinical course than males in terms of several inﬂammatory lung conditions. Notably, females with cystic ﬁbrosis (CF) suffer
worse outcomes, particularly in the setting of Pseudomonas aeruginosa infection. Sex
hormones have been implicated in experimental and clinical studies; however, immune mechanisms responsible for this sex-based disparity are unknown and the
speciﬁc sex hormone target for therapeutic manipulation has not been identiﬁed.
The objective of this study was to assess mechanisms behind the impact of female
sex hormones on host immune responses to P. aeruginosa. We used wild-type and
CF mice, which we hormone manipulated, inoculated with P. aeruginosa, and then
examined for outcomes and inﬂammatory responses. Neutrophils isolated from mice
and human subjects were tested for responses to P. aeruginosa. We found that female mice inoculated with P. aeruginosa died earlier and showed slower bacterial
clearance than males (P ⬍ 0.0001). Ovariectomized females supplemented with 17␤estradiol succumbed to P. aeruginosa challenge earlier than progesterone- or vehiclesupplemented mice (P ⫽ 0.0003). 17␤-Estradiol-treated ovariectomized female mice
demonstrated increased lung levels of inﬂammatory cytokines, and when rendered
neutropenic the mortality difference was abrogated. Neutrophils treated with 17␤estradiol demonstrated an enhanced oxidative burst but decreased P. aeruginosa killing and earlier cell necrosis. The estrogen receptor (ER) antagonist ICI 182,780 improved survival in female mice infected with P. aeruginosa and restored neutrophil
function. We concluded that ER antagonism rescues estrogen-mediated neutrophil
dysfunction and improves survival in response to P. aeruginosa. ER-mediated processes may explain the sex-based mortality gap in CF and other inﬂammatory lung
illnesses, and the ER blockade represents a rational therapeutic strategy.
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I

n numerous inﬂammatory lung diseases, there is an increased severity in females
relative to males (1, 2). Asthmatics show a female predominance of the disease
speciﬁcally after puberty, accompanied by more physician visits, hospitalizations, and a
30% increase in asthma-related deaths in females compared to males (3–5). In chronic
obstructive pulmonary disease (COPD), the prevalence and overall mortality is greater
in females than in males (6, 7). In bronchiectasis, which is marked clinically by chronic
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lung infections, females are hospitalized signiﬁcantly more often than males and have
an increased risk for infection with pathogens associated with impaired immunity, such
as nontuberculous mycobacteria (2). In cystic ﬁbrosis (CF), a genetic disease which also
causes bronchiectasis, the prevalence is equal in males and females, but a clear
sex-speciﬁc mortality difference exists (8, 9). In fact, the life expectancy of females with
CF is nearly 3 years less than that of males (8, 9). CF mortality is strongly linked to
chronic infection with pathogens such as Pseudomonas aeruginosa, which frequently
targets the CF lung. Of note, females with CF also acquire P. aeruginosa at an earlier age
and have worse outcomes than males once infected (9, 10). These differences are
present despite investigators accounting for potential confounding factors such as
morphometrics, nutrition, and comorbidities (9). Previous studies have suggested that
sex hormones play a role in all of these diseases; here, we propose that this hormone
effect occurs via modulation of innate immune responses that can be evaluated in P.
aeruginosa lung infection models.
Levels of the major female sex hormones, estrogen and progesterone (P4), vary
during ovulatory cycles, pregnancy, and menopause (11, 12). The predominant form of
estrogen, 17␤-estradiol (E2), varies in concentration from 20 to 400 pg/ml in serum,
while tissue expression varies. There are two major estrogen receptor (ER) subtypes,
ER-␣ and ER-␤, each with a high afﬁnity for E2 (13). Their classic actions are genomic;
however, nongenomic membrane-associated ER effects are now also widely recognized
(13–15). The other major female sex hormone, P4, ranges from 300 to 10,000 pg/ml in
serum and acts via two main nuclear receptors, progesterone receptors A and B (PR-A
and PR-B) (16). ER and PR are expressed in lung tissue (17, 18).
E2 behaves differently in various tissues and diseases and has been shown to induce
a proinﬂammatory state in some settings and an anti-inﬂammatory state in others
(19–22). Thus, the impact of sex hormones is highly contextual and the direct effects of
ER and PR activation on innate immune responses in a P. aeruginosa model of lung
infection have not been thoroughly evaluated. Neutrophils, key drivers of innate
immunity, are one of the ﬁrst responders in the infectious and inﬂammatory process
and are known to be critical for the body’s defense against P. aeruginosa (23). ER are
expressed in neutrophils, though PR expression has not been well described (24–27).
Very limited data exist regarding the effect of sex hormones on neutrophil functions. ER
and PR activation has been shown to modulate degranulation and apoptosis of
neutrophils (27–29), but no work in this ﬁeld has been done related to the neutrophil
killing effect and other responses to P. aeruginosa.
In this study, we sought to use a hormone-manipulated mouse model of P. aeruginosa infection to test the impact of female sex hormones on survival and bacterial
clearance. We speciﬁcally focused on the impact of sex hormones on inﬂammation and
neutrophil responses to P. aeruginosa, using neutrophils from mice and humans with
and without CF. The ultimate goal of these studies was to improve the understanding
of the mechanism of sex differences in inﬂammatory lung diseases associated with
bacterial infection, such as CF, and determine the speciﬁc therapeutic target for sex
hormone manipulation.
RESULTS
Female mice are more susceptible to P. aeruginosa infection than male mice. To
investigate the impact of sex on lung infection and inﬂammation, we inoculated male
and female wild-type (WT) mice with P. aeruginosa, using an inoculum of 8.5 ⫻ 105 CFU.
Weight-matched female mice died signiﬁcantly earlier than male mice, with survival
differences noted as early as 30 h postinfection (P ⬍ 0.0001) (Fig. 1A). Females had an
almost 4-fold greater mortality rate than males and a markedly steeper decline in
weight than males (P ⬍ 0.0001) (Fig. 1C). Additional experiments with age-matched
mice of both sexes showed results that were consistent with the data for weightmatched animals (see Fig. S1 in the supplemental material). To determine if the rate of
bacterial clearance in these mice was different between sexes, we infected male and
female mice with a 0% lethal dose (LD0; 3.0 ⫻ 105 CFU) and measured the remaining
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FIG 1 Female mice are more susceptible to P. aeruginosa infection than male mice. (A) Male and female
C57BL/6 wild-type mice were infected with P. aeruginosa (8.5 ⫻ 105 CFU) and followed for up to 96 h (n ⫽
18 per group). Displayed are Kaplan-Meier survival plots (P ⬍ 0.0001). (B) Male and female C57BL/6
wild-type mice were infected with a mucoid P. aeruginosa strain, M57-15 at 1.2 ⫻ 106 CFU and followed for
up to 96 h (n ⫽ 6 per group). Displayed are Kaplan-Meier survival plots. *, P ⬍ 0.05. (C) Body weights for
the animals whose survival data are shown in panel A. *, P ⬍ 0.0001. (D) Bacterial CFU remaining in the
lungs of male versus female mice after infection with P. aeruginosa at 3 ⫻105 CFU (n ⫽ 6 to 8 mice per time
point per group). *, P ⬍ 0.05. Data in panels B and C are mean results ⫾ SEM.

CFU in lungs over time. By 6 h after infection, male mice displayed a signiﬁcantly
decreased bacterial burden and an overall higher rate of bacterial clearance from their
lungs compared to females (P ⫽ 0.0100) (Fig. 1D). These experiments were repeated
using a mucoid clinical isolate of P. aeruginosa, M57-15, and the results were consistent
with those seen with strain PAO1, with female mice dying signiﬁcantly earlier than male
mice (Fig. 1B). Bacteremia was not detected in studies using nonlethal doses of PAO1
or lethal doses of M57-15 (Table S1).
Estrogen-supplemented male and female mice demonstrated decreased P.
aeruginosa clearance, independent of progesterone. To determine whether the
principal sex hormones, E2 and P4, could account for the male versus female differences seen previously, female mice were ovariectomized and supplemented with
vehicle, E2, or P4 at physiologic doses or sham ovariectomized, 10 to 14 days prior to
challenge with P. aeruginosa. The E2 effect was conﬁrmed by measuring uterine wet
weights, which were signiﬁcantly greater in the E2-supplemented mice than in ovariectomized mice (Fig. S2A). Serum measurements of E2 and P4 in hormone-treated mice
conﬁrmed signiﬁcant differences from untreated ovariectomized mice (Fig. S2B and C).
Following P. aeruginosa inoculation, E2-supplemented ovariectomized female mice
died signiﬁcantly earlier than vehicle-treated (P ⫽ 0.0023) or P4-supplemented mice
(P ⫽ 0.0007) (Fig. 2A), with a median survival of 29.75 h for the E2 group, 25.00 h for
the sham ovariectomy group, 53.87 h for the vehicle group, and ⬎72 h for the P4
group. There was no detectable difference between vehicle-treated and P4-treated
groups (P ⫽ 0.4405), or between sham-ovariectomized and E2-treated groups (P ⫽
0.2393). We further evaluated clearance of P. aeruginosa 18 h after infection, as we had
previously observed that this was the time point with the greatest difference noted
between males and females in Fig. 1C. Ovariectomized mice supplemented with E2
demonstrated impaired bacterial clearance compared to vehicle-supplemented ovariectomized mice, a difference that was greater than 10-fold (P ⫽ 0.0027), but no
difference relative to P4-treated ovariectomized mice (P ⫽ 0.0693) (Fig. 2B). ShamOctober 2017 Volume 85 Issue 10 e00422-17
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FIG 2 Estrogen-supplemented male and female mice demonstrated decreased P. aeruginosa clearance,
independent of progesterone. Wild-type C57BL/6 female mice were ovariectomized (OVX) and supplemented with physiologic doses of hormones. Veh, vehicle; Sham OVX, sham ovariectomized. The E2 dose
was 0.5 g/day, and P4 was administered at 2 mg/day. (A) Mice were infected with P. aeruginosa at 8.5 ⫻
105 CFU (n ⫽ 14 per group). Displayed are Kaplan-Meier survival plots. *, P ⬍ 0.05. (B) Bacterial CFU
remaining in the lungs 18 h after infection with P. aeruginosa (3 ⫻ 105 CFU) in the groups described for
panel A (n ⫽ 8 to 10 mice per group). Data are mean results ⫾ SEM. *, P ⬍ 0.05 (relative to vehicle or
relative to ovariectomized mice with vehicle; indicated by brackets to the right of the key on the right).
(C) Kaplan-Meier survival plots for male mice supplemented with vehicle (Veh) or E2 (0.5 g/day). *, P ⬍
0.05.

ovariectomized mice showed clearance proﬁles similar to those of E2-treated ovariectomized mice (P ⫽ 0.9641). Finally, male mice were supplemented with E2 or vehicle,
and they similarly demonstrated decreased survival in the E2-treated group (P ⫽
0.0018) (Fig. 2C). These experiments were repeated using M57-15 (30), and results were
consistent with those seen using PAO1, where ovariectomized female mice supplemented with estrogen died signiﬁcantly earlier than ovariectomized female mice
supplemented with vehicle (Fig. S3). Together, these ﬁndings suggest that E2 provides
a mortality risk associated with an impaired ability to clear bacteria.
Estrogen-dependent susceptibility to P. aeruginosa requires nuclear estrogen
receptors. To determine if the difference in ovariectomized mice supplemented with
E2 versus vehicle was ER speciﬁc, mice were supplemented with an ER antagonist, ICI
182,780, which blocks both nuclear and nonnuclear ERs. P. aeruginosa-infected ovariectomized mice treated with both E2 and ICI 182,780 had a longer survival time than
mice treated with E2 alone (P ⫽ 0.0399). As such, the poorer survival in E2supplemented mice was attenuated in the presence of ICI 182,780 (Fig. 3A). To further
October 2017 Volume 85 Issue 10 e00422-17
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FIG 3 Estrogen-dependent susceptibility to P. aeruginosa requires nuclear estrogen receptors. Survival of wild-type C57BL/6 female mice
with the indicated hormone treatment were infected with P. aeruginosa at 8.5 ⫻ 105 CFU. Kaplan-Meier survival plots are shown. (A)
Ovariectomized (OVX) female mice were treated with vehicle (Veh), E2 (0.5 g/day), ER antagonist (ICI 182,780 [500 g/day]), or a
combination (n ⫽ 8 per group). (B) Ovariectomized female mice were treated with vehicle, E2, membrane estrogen receptor agonist (EDC,
0.5 g/day), or dendrimer vehicle (Dend Veh) (n ⫽ 6 per group). (C) Ovariectomized female mice were treated with vehicle, E2, ER-␣
agonist (PPT, 250 g/day), or ER-␤ agonist (DPN, 250 g/day) (n ⫽ 12 per group). (D) Female mice with intact endogenous sex hormones
were treated with vehicle or ICI 182,780 (500 g/day). *, P ⬍ 0.05 (for data in all four panels).

evaluate the effect of nuclear versus nonnuclear ER, we used an estrogen dendrimer
conjugate (EDC), which is an extranuclear ER agonist. Female mice were ovariectomized
and supplemented with E2 or EDC and compared to control mice. EDC-treated ovariectomized mice had no detectable difference in survival relative to the dendrimer
vehicle-treated group (P ⫽ 0.9627) (Fig. 3B), demonstrating that selective activation of
nonnuclear ERs does not impact the host response to P. aeruginosa infection. We
subsequently evaluated the role of the two well-established nuclear ERs, ER-␣ and ER-␤,
using propyl pyrazole triol (PPT; ER-␣ agonist) and diarylpropionitrile (DPN; ER-␤
agonist), and we observed that both ER agonist treatments decreased survival relative
to the vehicle-treated group (P ⫽ 0.0340 for PPT, P ⫽ 0.0237 for DPN) (Fig. 3C),
suggesting a role for both nuclear ERs in the impact of E2 on P. aeruginosa infection.
Finally, female mice with intact endogenous sex hormones were treated with ICI
182,780 and notably displayed improved survival in response to P. aeruginosa infection
(P ⫽ 0.0013) (Fig. 3D). Taken together, these ﬁndings support a speciﬁc role for nuclear
E2 signaling in mediating sex-dependent differences in mortality following P. aeruginosa infection.
Estrogen induces neutrophilic inﬂammation in the setting of P. aeruginosa
infection. We ﬁrst evaluated the direct effect of E2 and P4 on P. aeruginosa, and we
found no quantitative change in growth rate or qualitative changes to mucoid conversion (Fig. S4). Having identiﬁed no direct effect of E2 on P. aeruginosa infection, we
sought to determine if E2 impacted the host inﬂammatory response. We examined
gross sections and cytokine expression in E2-treated murine lungs harvested 9 h after
P. aeruginosa infection, a time after which a difference in bacterial clearance was
observed (Fig. 2). Examination of lung histopathology showed a notable increase in
inﬂammation in the setting of E2 treatment (Fig. 4A). Using a lung inﬂammation scoring
system previously described (31), we evaluated sections from vehicle- and E2-treated
ovariectomized mice infected with P. aeruginosa. E2-treated mice had higher peribronOctober 2017 Volume 85 Issue 10 e00422-17
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chial and perivascular inﬂammatory scores (P ⬍ 0.0001 [total]) (Fig. 4B). Lung homogenates were also evaluated 9 h after P. aeruginosa infection for cytokine expression in
ovariectomized mice treated with vehicle compared to E2. We observed signiﬁcant
increases in the inﬂammatory cytokines tumor necrosis factor alpha (TNF-␣), KC,
interleukin-10 (IL-10), and IL-6, as well as in chemokines, including granulocytemacrophage colony-stimulating factor (GM-CSF), monocyte chemoattractant protein 1
(MCP-1), macrophage inhibitory protein 1␣ (MIP-1␣), and MIP-1␤ (Fig. 4C). Cytokines
that showed no difference in expression at this time point included gamma interferon
(IFN-␥), IL-1␤, RANTES, granulocyte colony-stimulating factor (G-CSF), eotaxin, IL-17,
IL-13, IL-12(p70), IL-12(p40), IL-9, IL-5, IL-4, IL-3, IL-2, and IL-1␣ (data not shown).
Furthermore, the neutrophil granular proteins myeloperoxidase (MPO) and neutrophil
elastase (NE) were signiﬁcantly more abundant in lung tissue from E2-treated mice (Fig.
4C). Lung homogenates were also evaluated 18 h after infection and showed similar
results to those seen at 9 h (Fig. S5). The histologic changes and elevated inﬂammatory
cytokine responses in the E2-treated mice were consistent with a neutrophilpredominant response.
The neutrophil response to P. aeruginosa infection is regulated by 17␤estradiol. Given that neutrophils play a critical role in the host response to bacterial
infection, we quantiﬁed the total number of neutrophils in the lungs of E2-treated
versus vehicle-treated mice exposed to P. aeruginosa. We used ovariectomized mice
treated with vehicle or E2 and infected them with P. aeruginosa at the LD0 of 3 ⫻ 105
CFU. Whole lung tissue and bronchoalveolar lavage (BAL) ﬂuid samples demonstrated
no differences in neutrophil numbers by ﬂow cytometry between vehicle and E2
treatment at any time point (P ⬎ 0.05) (Fig. 5A and B). Although no quantiﬁable
October 2017 Volume 85 Issue 10 e00422-17
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FIG 4 Estrogen induces neutrophilic inﬂammation in the setting of P. aeruginosa infection. Wild-type C57BL/6 mice were ovariectomized and treated with
vehicle or E2 at 0.5 g/day and then infected with P. aeruginosa at 3.0 ⫻105 CFU/ml for 9 h. (A) Lung inﬂammation in representative histological images stained
with hematoxylin and eosin. Scale bars, 100 m. (B) Peribronchial, perivascular, and total lung inﬂammation scores were measured from lung sections taken
9 h after infection (treatment groups as described for panel A) (n ⫽ 7 mice per group; examination of 12 ﬁelds per slide). (C) Cytokine expression in whole lung
samples of female mice ovariectomized and hormone treated as for panel A. Cytokines were assyed 9 h after infection (n ⫽ 8 mice per group). Data are
expressed as mean results ⫾ SEM. *, P ⬍ 0.05.
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FIG 5 The neutrophil response to P. aeruginosa infection is regulated by 17␤-estradiol. (A) Percentage and number
of absolute neutrophils from whole lungs of C57BL/6 mice 9 h after P. aeruginosa infection with 3 ⫻105 CFU,
quantiﬁed by ﬂow cytometry (n ⫽ 6 mice per group per time point). (B) Percentage and absolute neutrophil counts
from bronchoalveolar lavage ﬂuid, quantiﬁed by ﬂow cytometry (n ⫽ 6 per group per time point). (C) Kaplan-Meier
survival plots of C57BL/6 ovariectomized and hormone-treated female mice rendered neutropenic by using the 1A8
monoclonal antibody (anti-Ly6G antibody). Ovariectomized mice were infected with 8 ⫻ 104 CFU of P. aeruginosa
(n ⫽ 8 per group). (D) Neutrophils were isolated from mice and used ex vivo for P. aeruginosa killing experiments
at an MOI of 1:4 under the indicated treatment conditions (n ⫽ 5 per treatment group). Data in panels A, B, D, and
E are mean results ⫾ SEM. *, P ⬍ 0.05 compared to vehicle.

difference in neutrophil counts was seen, neutrophil granular proteins, including MPO
and NE, were signiﬁcantly higher in E2-treated mice (Fig. 4C), suggesting an important
role for neutrophils in ER modulation of the host response to P. aeruginosa infection. To
test the impact of neutrophils, we studied ovariectomized female mice supplemented
with vehicle and E2 and rendered them neutropenic using a monoclonal LY6G clone
1A8 anti-granulocyte receptor antibody. After conﬁrming neutropenia in peripheral
blood (white blood cell counts of ⬍250/l), we inoculated mice with P. aeruginosa at
a dose of 8 ⫻ 104 CFU, which preliminary experiments had shown was a lethal dose for
neutropenic female mice. After neutropenia, the effect of E2 on survival following P.
aeruginosa infection was abrogated (P ⫽ 0.655) (Fig. 5C), suggesting that neutrophils
are a target of E2 activation in the hormonal modulation of the host response to P.
aeruginosa infection. To more directly test the effect of E2 on neutrophil function, we
isolated neutrophils from bone marrow cells of female mice and exposed the cells to
vehicle and E2 before performing killing assays with P. aeruginosa. The ability of
neutrophils to kill P. aeruginosa was hindered in the presence of escalating doses of E2,
as demonstrated by increased CFU seen with E2 (P ⫽ 0.0310) (Fig. 5D).
October 2017 Volume 85 Issue 10 e00422-17
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FIG 6 Estrogen receptor antagonists improve survival in CFTR⫺/⫺ female mice infected with P. aeruginosa. Kaplan-Meier survival plots of CFTR⫺/⫺ mice hormonally manipulated as indicated and then treated
with 3 ⫻ 105 CFU of P. aeruginosa. (A) Hormonal intact male and female CFTR⫺/⫺ mice (n ⫽ 10 per
group). (B) Ovariectomized (OVX) CFTR⫺/⫺ mice treated with Vehicle or E2 (n ⫽ 9 per group). (C) CFTR⫺/⫺
intact females treated with vehicle or ICI 182,780 (ICI) (n ⫽ 10 per group). *, P ⬍ 0.05.

Estrogen receptor antagonists improve survival in CFTRⴚ/ⴚ female mice infected with P. aeruginosa. To determine the impact of ER modulation in a clinically
relevant model of P. aeruginosa lung infection, a CFTR-deﬁcient mouse model
(CFTRtm1UNC) was tested. Hormone-intact male and female mice were treated with P.
aeruginosa at a dose of 3 ⫻ 105 CFU, which we determined is a lethal dose for this strain
of mice. Median survival in female mice was 32.1 h, versus 48.0 h in male mice (P ⬍
0.0001) (Fig. 6A). Ovariectomized female mice supplemented with vehicle or E2 showed
worse survival in the E2-treated mice, consistent with the results in WT mice (P ⫽
0.0008) (Fig. 6B). Treatment with ICI 182,780 improved survival in CFTR-null intact
females infected with P. aeruginosa (P ⫽ 0.0013), similar to the effect observed in WT
mice (Fig. 3D) and suggesting a potential role for ER antagonists in the treatment of P.
aeruginosa infection in CF (Fig. 6C). Survival differences in male and female CFTR-null
mice or between vehicle-treated and estrogen-supplemented, ovariectomized female
mice were not notably greater than those seen in wild-type mice, suggesting that the
E2 effect is not mediated by CFTR.
17␤-Estradiol impacts responses to P. aeruginosa infection of neutrophils from
subjects with CF. Having demonstrated that E2 inhibits neutrophil function in mice
October 2017 Volume 85 Issue 10 e00422-17
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FIG 7 17␤-Estradiol impacts responses to P. aeruginosa infection of neutrophils from subjects with CF. (A)
Neutrophils from female subjects with CF treated ex vivo with E2 and ICI 182,780 (ICI) at the indicated doses
were subjected to P. aeruginosa killing assays at an MOI of 1:4 (n ⫽ 20 per group). (B) Neutrophils from male
subjects with CF treated ex vivo with E2 and ICI 182,780 (ICI) at the indicated doses were analyzed in P.
aeruginosa killing assays at an MOI of 1:4 (n ⫽ 5). Data shown are mean results ⫾ SEM. *, P ⬍ 0.05 relative
to vehicle. (C) Neutrophils similar to those desribed for panel A were treated with E2 and ICI 182,780 for
oxidative burst assays induced by P. aeruginosa. Chemiluminescence (CLU) is expressed as the mean result ⫾
SEM (n ⫽ 6 per group). *, P ⬍ 0.05 (AUC). (D) NE expression in CF neutrophils treated with vehicle or E2. Data
shown are the mean results ⫾ SEM (n ⫽ 6). *, P ⬍ 0.05. (E) Neutrophil death was assayed via LDH release at
the indicated time points (n ⫽ 6 per group). *, P ⬍ 0.05 relative to vehicle with PAO1 and vehicle without
PAO1. Shown in panels A, C, and D are the mean results ⫾ SEM. *, P ⬍ 0.05 relative to vehicle.

(Fig. 5D), we sought to determine if this was present in humans and if the E2 effect on
neutrophils was ER speciﬁc. We therefore used neutrophils from female subjects with
CF to evaluate the effect of ER antagonists on the neutrophil killing capacity against P.
aeruginosa. Stable CF subjects with a wide range of forced expiratory volume levels,
genotypes, and bacterial proﬁles were recruited (Table S2). The effect of E2 on neutrophil killing was attenuated in a dose-dependent fashion with ER antagonism via ICI
182,780 (Fig. 7A). Consistent with our mouse data (Fig. 3D), we found that both nuclear
ERs contributed to the ER effect, based on a signiﬁcantly lower CFU at all concentrations
of E2 (P ⬍ 0.0001). We also evaluated bacterial killing of neutrophils from female
October 2017 Volume 85 Issue 10 e00422-17
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subjects without CF (healthy females), and the results were similar to those seen in
females with CF (Fig. S6). We further evaluated neutrophils from males with CF and
found P. aeruginosa killing responses similar to those seen in females. However, the
neutrophils of males did not have a reduction in killing with E2 stimulation to the same
extent as seen with female neutrophils (Fig. 7B). To further determine how E2 impacts
the neutrophil response to infection, we evaluated the respiratory burst, which is a
critical measure of the oxygen-dependent pathway of the neutrophil response to
invading pathogens. We found E2 enhanced oxidative burst activity with both an earlier
peak and a more robust response (P ⫽ 0.0235) (Fig. 7B). This was conﬁrmed by
demonstrating increased release of NE when the cells were stimulated with E2 (P ⫽
0.0088) (Fig. 7C). Furthermore, E2 promoted earlier neutrophil cell death upon stimulation with P. aeruginosa (P ⫽ 0.0005) (Fig. 7D). Together, these ﬁndings implicate E2 as
a cause for premature and exaggerated neutrophil activation and earlier death of
neutrophils, which translate to a reduced ability of neutrophils to kill P. aeruginosa.
DISCUSSION
This study demonstrated that ER activation interferes with the host response to P.
aeruginosa infection, in part through a neutrophil-dependent mechanism, and is attenuated by an ER antagonist. The E2 effect is driven by both nuclear ER-␣ and ER-␤
activation, but not by nonnuclear ER activation. We showed that the effect was
consistent in mice infected with P. aeruginosa, in both wild-type mice and in the
clinically relevant model of CFTR-deﬁcient mice. In each model, E2 stimulation resulted
in increased inﬂammatory cytokine expression and decreased survival and ability to
clear bacteria. The E2 effect was abrogated when mice were rendered neutropenic,
suggesting a central role for neutrophils in the mechanism affected by ER activation.
Findings in mice were validated in human samples, again using a clinically relevant
population that was infected with P. aeruginosa. E2-stimulated neutrophils isolated
from female relative to male CF individuals showed early and overexuberant activation,
demonstrated by a heightened oxidative burst and increased release of the intracellular
granular proteins MPO and NE. Ultimately, under E2 treatment conditions, neutrophils
underwent earlier death, which correlated with an impaired functional killing capacity
for P. aeruginosa. Together, these data suggest that there is a dysregulated proinﬂammatory response and altered neutrophil function in the setting of ER activation during
P. aeruginosa infection, and they provide a rational basis for the observed sex differences in both non-CF and CF subjects. Attenuation of this dysregulated response with
the use of an ER antagonist may present a novel therapeutic approach to such
infections.
Previous studies suggested that estrogens may impact P. aeruginosa infection in CF
patients. An association was reported between pulmonary exacerbations and high E2
levels in women with CF and that study further showed that E2 promoted the in vitro
conversion of P. aeruginosa from a nonmucoid to mucoid form after 4 weeks of daily
E2 treatment (32). The relevance of these ﬁnding is unclear, as the other authors did not
employ an ER antagonist to demonstrate ER speciﬁcity. We did not observe a morphological conversion of P. aeruginosa from a nonmucoid to mucoid type with E2 or P4
treatment, nor did we see a change in the rate of bacterial growth. The lack of mucoid
conversion may be explained by the fact that our study periods were less than 96 h,
whereas the previous study noted mucoid conversion after several weeks. We were also
unable to ﬁnd ER or PR expression in the PAO1 genome. Our observations indicate that
the impact of E2 on P. aeruginosa infection is primarily due to an alteration in the host
response rather than a direct effect on the bacterium.
E2 has been reported to have both pro- and anti-inﬂammatory effects in different
organ systems (19, 33–35). The role of sex hormones has been investigated in experimental models of infection and inﬂammation with varied results. Inﬂammatory responses were worse in female than male mice injected with intrapleural carrageenan in
a model that implicated the ER-␣ signaling pathway (21). A lung allergen-induced
mouse model showed that progesterone inﬂuences the Th2 inﬂammatory response
October 2017 Volume 85 Issue 10 e00422-17
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(22). In a model of pneumococcal pneumonia, macrophages from male and female
mice treated with estrogen were more efﬁcient in ingesting bacteria; however, the
speciﬁc sex hormone signaling pathway was not identiﬁed (36). The speciﬁc inﬂammatory cell that leads to increased morbidity and mortality in infectious and inﬂammatory lung diseases has not been identiﬁed. More importantly, if sex hormone
pathways were to be modulated pharmacologically in human trials, the speciﬁc estrogen receptor to be blocked also has not been deﬁned. Consistent with our ﬁndings, ER
activation has been shown to induce a proinﬂammatory response in CFTR⫺/⫺ male
mice infected with P. aeruginosa (37). However, we further revealed that the E2
response is driven by nuclear ER-␣ and ER-␤ receptor activation and does not involve
nonnuclear ER involvement and also that the increase in inﬂammation results in
diminished bacterial clearance and increased death in E2-treated mice. PPT and DPN
were employed to assess ER-␣ and ER-␤ activities, rather than ER knockout mice,
because ER-␤ knockout mice in particular are known to have decreased numbers of
alveoli in adult female mice and altered surfactant homeostasis, which we felt would
complicate interpretation of studies (38). We also showed that the death rate could be
improved by using the ER-␣ and ER-␤ antagonist ICI 182,780. In contrast to prior
studies, we did not ﬁnd a quantitative difference in neutrophils in the lungs of
E2-treated mice (37). We instead demonstrated that the neutrophils recruited to sites
of inﬂammation are less capable of clearing P. aeruginosa and undergo overexuberant
activation and enhanced cell death upon E2 treatment. Furthermore, we did not ﬁnd a
direct connection to CFTR and host susceptibility to infection under E2 stimulation.
Therefore, our ﬁndings are also relevant to the sex-dependent differences in the
outcomes of those with airway diseases where neutrophils also play a role in the
pathophysiology of airway inﬂammation, including asthma and COPD (39, 40).
Historically, elevated levels of the neutrophil intragranular proteins MPO and NE in
the CF lung were thought to be directly proportional to increased numbers of neutrophils rather than increased release from individual neutrophils. Importantly, TNF-␣ and
IL-8 have been shown to promote increased release of NE from neutrophils (41). Our
data support this ﬁnding in that we showed increased expression of several cytokines,
including TNF-␣ and IL-8, in the presence of ER activation but no quantitative differences in neutrophil counts despite higher levels of MPO and NE in lung tissues. We
further showed that E2 induces an earlier and more exaggerated oxidative burst and NE
elastase release in neutrophils isolated from CF female subjects, supporting a role for
estrogens in the complex mechanisms governing neutrophil activation and degranulation. Increased release of reactive oxygen species results in a protease-antiprotease
imbalance that leads to long-term tissue destruction (42). Excessive NE in CF as well as
COPD is associated with more severe disease and may explain in part the worse
outcomes in females with these diseases (40, 43).
In conclusion, we have shown in a murine model of P. aeruginosa respiratory
infection and in human neutrophils that ER activation has a pivotal role in enhancing
inﬂammation and activating neutrophils but that it hinders important neutrophil killing
functions, which can be attenuated with an ER antagonist. Together, these data suggest
a dysregulated host immune response to P. aeruginosa infection in the presence of E2.
Modulation of ER activation or downstream ER pathways may represent novel treatment targets to improve host immunity and thereby narrow the gap in outcomes
between males and females with CF and other inﬂammatory lung diseases.
MATERIALS AND METHODS
Mice. WT and CF (CFTRtm1UNC) male and female mice in a C57BL/6 background were used for all
studies. Animal protocols were approved by the Institutional Animal Care and Use Committee at the
University of Texas Southwestern. Female mice were ovariectomized at 4 to 6 weeks of age and treated
with hormones. Pellets were inserted subcutaneously in the nape of the neck that released vehicle only,
E2 (0.5 g/day), or P4 (2 mg/day) (Innovative Research of America, Sarasota, FL). To modulate ER,
ovariectomized mice were treated with E2 (0.5 g/day), ICI 182,780 (500 g/day), PPT (250 g/day), or
DPN (250 g/day) by subcutaneous infection (Tocris, Minneapolis, MN). To modulate the nongenomic ER,
we used EDC and its dendrimer control (44). These ovariectomized mice were implanted with intraperitoneal osmotic minipumps (model 2006; Durect Corp., Cupertino, CA) that delivered EDC at an estrogen
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dose equivalent to 0.5 g/day (45). Male mice were treated daily with subcutaneous injections of E2
(0.5 g/day) or vehicle.
Pseudomonas aeruginosa infection. P. aeruginosa strain PAO1 (ATCC, Manassas, VA) was used for
all described bacterial studies (46). Bacteria were streaked from frozen glycerol stocks onto Trypticase soy
agar (TSA) plates and incubated overnight at 37°C. Overnight cultures were washed in 150 nM sodium
chloride, and ﬁnal pellets were resuspended in 1 ml of Luria-Bertani (LB) broth. Culture concentrations
were calculated based on the optical density at 600 nm (OD600) and the previously determined number
of CFU for each strain, to give the CFU/OD600. Mice were inoculated intranasally with 50 ul of P.
aeruginosa at low doses (3.5 ⫻ 105 CFU) for bacterial clearance assays and at high doses (8.5 ⫻ 105) for
survival assays. Right and left lungs were harvested and homogenized for quantiﬁcation of CFU per lung,
histological assessment, determination of inﬂammatory cytokines in the lung, and cell counts via ﬂow
cytometry (47). Survival assays were also conducted in mice infected with the mucoid clinical P.
aeruginosa isolate M57-15 at 1.2 ⫻ 106 CFU (described further in the supplemental material) (30, 48).
Male and female mice were infected with PAO1 at 3.5 ⫻ 105 CFU and 8.5 ⫻ 105 CFU as well as
M57-15 at 1.2 ⫻ 106 CFU. A subset of mice were euthanized 24 h postinfection and blood was drawn
by cardiac puncture and sent to IDEXX Bioresearch (Columbia, MO) for microbiologic evaluation.
Results are shown in Table S1.
Mucoid Pseudomonas aeruginosa infection. A mucoid P. aeruginosa clinical isolate, M57-15, was
provided by Carolyn Cannon (Texas A&M University, College Station, TX). Bacteria were streaked from
frozen glycerol stocks onto Trypticase soy agar plates and incubated overnight at 37°C. Overnight
cultures were washed in 150 mM sodium chloride, and ﬁnal pellets were resuspended in 1 ml Tryptic soy
broth. Concentrations were calculated using the CFU/OD600 with the previously determined number of
CFU for each strain. Mice were inoculated with 1.2 ⫻ 106 CFU of M57-15 for survival experiments based
on reports in the previous literature (30, 48). Male and female C57BL/6 wild-type mice were infected with
M57-15 and followed for up to 96 h (n ⫽ 6 per group) (Fig. S3). A subset of mice were euthanized 24 h
postinfection and blood was drawn by cardiac puncture and sent to IDEXX Bioresearch (Columbia, MO)
for culture to detect bacteremia. Results are shown in Table S1.
Bronchoalveolar lavage ﬂuid and tissue collection. Two weeks after ovariectomy and hormone
treatments, mice were infected with P. aeruginosa and then euthanized at different time points. BAL was
performed by surgically exposing the trachea and inserting a plastic catheter (21 gauge). To lavage, 1 ml
of cold phosphate-buffered saline (PBS) was introduced slowly into the lungs, and ﬂuid was withdrawn
three times and kept on ice. Lungs were then processed for ﬂow cytometry and histology. Lungs were
washed with PBS, homogenized, and kept on ice. In separate experiments, the lung vasculature was
perfused, inﬂation ﬁxed with 4% paraformaldehyde (PFA), and then parafﬁn embedded. Inﬂammatory
cytokines in the lung were determined using a multianalyte assay (Bio-Rad, Hercules, CA). Select
cytokines, MPO, and NE were measured based on colorimetric activity and enzyme-linked immunosorbent assay results, respectively.
Flow cytometry. Cells were obtained from BAL ﬂuid and minced lung homogenates by centrifugation, pelleted, and ﬁxed for 1 min in 2 ml of intracellular ﬁxative (eBioscience, San Diego, CA). The ﬁxation
reaction was stopped by the addition of 10 ml of ice-cold ﬂow cytometry wash buffer (FWB) composed
of PBS containing 2% fetal calf serum (FCS), 0.1% sodium azide, and 5 mM EDTA. The suspension was
subsequently ﬁltered through a 40-m nylon membrane and washed again with 10 ml of ice-cold FWB.
The single-cell suspension was centrifuged at 4°C at 1,282 ⫻ g. The cell pellet was resuspended in 1 ml
of ﬂow cytometry wash buffer and placed on ice. For in vitro antibody staining, single-cell suspensions
were incubated with ﬂuorochrome-conjugated antibodies for 30 min in a dark at room temperature (RT).
Antibodies used to identify myeloid cells included CD45 (clone 30-F1; BD Pharmigen, San Jose, CA), CD24
(clone M1/69; BD Pharmigen), Ly6G (clone 1A8; BD Pharmigen), and F4/80 (clone BM8; Biolegend);
propidium iodide (PI) staining solution was used to label dead cells (BD Biosciences, San Jose, CA). After
incubation, 4 ml of FWB was added to the single-cell suspensions and centrifuged at 1,282 ⫻ g at 4°C
for 5 min. Cells were resuspended in FWB and analyzed with a four-channel FACSCalibur ﬂow cytometer
(Beckman Coulter, Brea, CA). Data were analyzed with FlowJo software (Treestar, Ashland, OR).
Histology and immunohistochemistry. Lung tissues from ovariectomized and E2-supplemented
WT mice inoculated with vehicle or P. aeruginosa were ﬁxed with 4% PFA and embedded in parafﬁn to
produce 3-m-thick sections. The sections were stained with hematoxylin and eosin (H&E). Histology was
evaluated by two different parties, blinded to the treatment groups and using a scoring system modiﬁed
from those previously described (31, 49, 50). The degree of peribronchial and perivascular inﬂammation
was evaluated on a scale of 0 to 3. A value of 0 was assigned when no inﬂammation was detectable, a
value of 1 was designated for occasional cufﬁng with inﬂammatory cells, a value of 2 was designated
when the surrounding area of most bronchi and vessels showed loosely arranged inﬂammatory cells, and
a value of 3 was given when the surrounding area of most bronchi and vessels contained a thick layer
of densely packed inﬂammatory cells. Total lung inﬂammation was determined as the average of the
peribronchial and perivascular inﬂammation scores.
Murine neutrophil isolation. Murine bone marrow leukocyte isolation was performed using a
modiﬁcation of a previously described protocol, and cells were kept on ice prior to use (47). Brieﬂy, mice
were anesthetized using Avertin injection prior to cervical dislocation. The skin was cleansed with alcohol
and the femur and tibia were removed bilaterally. The bones were cleaned of debris, and washed in
Hanks’ balanced salt solution (HBSS; HyClone, Pittsburgh, PA). Cells were isolated at 500 ⫻ g for 10 min
at RT. Cells were then resuspended in 45% Percoll–Dulbecco’s phosphate-buffered saline solution
(Sigma, St. Louis, MO) and aspirated twice through a 22-gauge needle and syringe to break up dense
bone marrow tissue. Cell-Percoll solutions were layered atop a Percoll density gradient (prepared by
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underlaying 2 ml of 52, 69, and 78% Percoll–Dulbecco’s phosphate-buffered saline solutions) and
centrifuged at 500 ⫻ g for 30 min at RT. Neutrophils were collected from the 78% Percoll solution
interface, washed twice with 10 ml of HBSS supplemented with bovine serum albumin and glucose
(1,400 ⫻ g for 5 min at RT), and then resuspended in buffer. Cells were counted using a hemocytometer,
attached to glass slides by centrifugation, and stained for differential analysis.
Human neutrophil isolation and assays. Human sample collection and data collection for these
studies were approved by the Institutional Review Board at UT Southwestern and required signed
consent from each participant. Blood was collected in acid citrate dextrose anticoagulant (Vacutainer
ACD solution A; BD Biosciences, San Jose, CA) and centrifuged at 425 ⫻ g for 10 min to separate the
plasma from the hemocytes. The hemocytes were diluted with calcium, magnesium-free HBSS (HBSS⫺)
to the lesser of 25 or 50 ml, and mixed with an equal volume of 3% dextran 500 (MP Biochemicals, Santa
Ana, CA) dissolved in HBSS⫺. While the erythrocytes were settling in dextran, the plasma from the
ﬁrst spin was spun again to enhance leukocyte recovery. The resulting plasma was then centrifuged
at 1,847 ⫻ g for 10 min to remove platelets. After the erythrocytes formed a distinct phase (20 to
30 min), the supernatant was removed from the aggregated erythrocytes by centrifugation for 10
min at 425 ⫻ g. The resulting pellet was diluted in 10 ml of 33 mM NaCl followed 30 s later by 10 ml
of 267 mM NaCl to restore isotonicity. The tube was ﬁlled with HBSS⫺, spun as before, and the lysis was
repeated. The pellet was then resuspended in 2 ml of HBSS⫺ and overlaid on a discontinuous gradient
of Percoll, to 51% (bottom layer) and 42% (top layer). The gradient was centrifuged for 10 min at 425 ⫻ g,
and the neutrophil-rich pellet was resuspended and washed once in HBSS⫺. Purity of neutrophils
prepared by this method was typically 95 to 99% (51). Neutrophil killing assays, luminol-enhanced
neutrophil chemiluminescence, and cytotoxicity assays were performed as previously described (51–55).
Killing assays. Neutrophil killing assays were performed in nonpyrogenic polystyrene 96-well plates
(Falcon tissue culture plates; BD Biosciences). Neutrophils were preincubated for 2 h with vehicle, E2, and
ICI 182,780, an estrogen receptor antagonist, at different concentrations. P. aeruginosa was added at a
multiplicity of infection (MOI) of 1:4 in a total volume of 300 l that contained Roswell Park Memorial
Institute (RPMI) 1640 medium with L-glutamine (Invitrogen, Carlsbad, CA) and 25 mmol/liter HEPES (pH
7.5; HyClone, Pittsburgh, PA) in the presence or absence of 10% autologous serum. The doubling time
of PAO1 in our experiments was 20 to 25 min, consistent with previous reports in the literature, such that
our ﬁnal concentrations of P. aeruginosa reached ranges of 109 CFU/ml, which is within physiologic
concentrations described in sputum of patients with CF (56, 57). Plates were incubated at 37°C with 5%
carbon dioxide. After 4 h, the cells were placed on ice and treated with saponin (ﬁnal concentration,
0.1%; Sigma-Aldrich, St. Louis, MO) for 10 min, followed by mechanical shearing with a 28-gauge needle
and with a 0.5-ml syringe. Supernatants were diluted and spread on LB plates and then CFU were
counted (52).
Luminol-enhanced neutrophil chemiluminescence. Neutrophils were suspended at 1 ⫻ 106/ml in
RPMI 1640 medium with 5% autologous serum, 27.5 mM HEPES (pH 7.4), and 55 M luminol (Fisher
Scientiﬁc, Pittsburg, PA), and 90 l was aliquoted into a 96-well plate. Neutrophils were preincubated for
2 h with vehicle or E2 at doses of 1, 10, and 100 nM at 37°C in a 5% CO2 incubator, and 10 l of washed
bacteria (MOIs, 100:1, 10:1, 1:1) was suspended in saline and added to the plate. Saline alone was added
as a control, and the luminometer (Anthos Zenyth 3100, Hilliston, MA) was set at 37°C, with readings of
1 s per well acquired every 2.4 min (52, 53, 58). Results are expressed kinetically or converted to the area
under the concentration-time curve (AUC) using the Prism 5.0 software package (GraphPad, La Jolla, CA)
(52).
Neutrophil cytotoxicity assay. Neutrophils were suspended at 2 ⫻ 106/ml in RPMI 1640 medium
with 1% human AB serum (Atlanta Biologicals, Flowery Branch, GA). Neutrophils were preincubated with
vehicle and E2 at concentrations of 1 to 100 nM for 2 h. After preincubation, washed P. aeruginosa cells
were added to each well at an MOI of 1:10 (52, 58). Two sets of replicates for each condition were used:
one for the high control and one for the sample. After 3, 6, 9, and 12 h, the wells for maximal lysis control
were treated with 5% Triton X-100 (Sigma, St. Louis, MO) and mixed thoroughly using a multichannel
pipette to ensure the cells membranes were properly degraded. The plate was then centrifuged for 10
min at 51 ⫻ g. Supernatant (100 l) from the top of all the wells was added to a new assay plate in a
volume of 100 l for determination of lactate dehydrogenase (LDH) levels according to the manufacturer’s instructions (cytotoxicity detection kit; Roche, Branchburg, NJ) and using a standard plate reader
with a reference wavelength of 490 nM (54, 55). The cytotoxicity percentage was determined as follows:
(experimental value) ⫺ [(low control)/(high control ⫺ low control)] ⫻ 100.
Statistical analysis. Data were analyzed using Prism 6.0 (GraphPad Software, San Diego, CA). Survival
analysis was performed by the Kaplan-Meier method using log rank analysis. Experimental results were
analyzed using Student’s t test for two samples or a two-way analysis of variance (ANOVA) with Tukey’s
multiple-comparison test for evaluation of three or more groups. Results are expressed as means ⫾
standard errors of the means (SEM) of separate replicates as indicated in the ﬁgure legends. P values were
considered statistically signiﬁcant if P was ⬍0.05.
Further details concerning our methods are provided in the supplemental material.

SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/IAI
.00422-17.
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